Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emiko Sano

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Oncology Letters|September 16, 2020
Antitumor effects of ribavirin in combination with TMZ and IFN-β in malignant glioma cellsYushi Ochiai, Koichiro Sumi, Emiko Sano, et al.
Oncology Reports|April 24, 2020
Antitumor effect of lenalidomide in malignant glioma cell linesYuya Hanashima, Emiko Sano, Koichiro Sumi, et al.
Oncology Letters|October 26, 2022
Anti-tumor effects of perampanel in malignant glioma cellsJuri Tatsuoka, Emiko Sano, Yuya Hanashima, et al.
Oncology Letters|November 4, 2014
Efficacy of ribavirin against malignant glioma cell linesAkiyoshi Ogino, Emiko Sano, Yushi Ochiai, et al.
International Journal of Oncology|September 24, 2015
Antitumorigenic effect of interferon-β by inhibition of undifferentiated glioblastoma cellsShun Yamamuro, Emiko Sano, Yutaka Okamoto, et al.
Oncology Reports|December 19, 2017
Efficacy of ribavirin against malignant glioma cell lines: Follow-up studyYushi Ochiai, Emiko Sano, Yutaka Okamoto, et al.
Science Signaling|January 19, 2012
Interleukin-11 links oxidative stress and compensatory proliferationTakashi Nishina, Sachiko Komazawa-Sakon, Saeko Yanaka, et al.
The Journal of Biological Chemistry|December 9, 2010
Non-core region modulates interleukin-11 signaling activity: generation of agonist and antagonist variantsSaeko Yanaka, 中冴子 谷, Emiko Sano, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Oncology Letters|September 16, 2020
Antitumor effects of ribavirin in combination with TMZ and IFN-β in malignant glioma cellsYushi Ochiai, Koichiro Sumi, Emiko Sano, et al.
Oncology Reports|April 24, 2020
Antitumor effect of lenalidomide in malignant glioma cell linesYuya Hanashima, Emiko Sano, Koichiro Sumi, et al.
Oncology Letters|October 26, 2022
Anti-tumor effects of perampanel in malignant glioma cellsJuri Tatsuoka, Emiko Sano, Yuya Hanashima, et al.
Oncology Letters|November 4, 2014
Efficacy of ribavirin against malignant glioma cell linesAkiyoshi Ogino, Emiko Sano, Yushi Ochiai, et al.
International Journal of Oncology|September 24, 2015
Antitumorigenic effect of interferon-β by inhibition of undifferentiated glioblastoma cellsShun Yamamuro, Emiko Sano, Yutaka Okamoto, et al.
Oncology Reports|December 19, 2017
Efficacy of ribavirin against malignant glioma cell lines: Follow-up studyYushi Ochiai, Emiko Sano, Yutaka Okamoto, et al.
Science Signaling|January 19, 2012
Interleukin-11 links oxidative stress and compensatory proliferationTakashi Nishina, Sachiko Komazawa-Sakon, Saeko Yanaka, et al.
The Journal of Biological Chemistry|December 9, 2010
Non-core region modulates interleukin-11 signaling activity: generation of agonist and antagonist variantsSaeko Yanaka, 中冴子 谷, Emiko Sano, et al.
Pageof 3